Licensed Practical Nurse in Paducah, KY Accepting Medicare

8 Licensed Practical Nurse nurses found. Showing 1 - 8

Robert J Burke, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2620 Perkins Creek Dr, Paducah, KY 42001 Phone: 270-444-8465    Fax: 270-443-7734

Jessica Heller, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2620 Perkins Creek Dr, Paducah, KY 42001 Phone: 270-444-8465

Shellon Katri Troutt, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2620 Perkins Creek Dr, Paducah, KY 42001 Phone: 270-444-8465

Ms. Heather L Webb, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 216 Berger Rd, Paducah, KY 42003 Phone: 270-441-0030    Fax: 270-441-9018

Yolanda E Heath, ND, CCA, LPN, CNC Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3530 Lone Oak Rd Ste A, Paducah, KY 42003 Phone: 270-534-4977

Aleisha D Hileman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2620 Perkins Creek Dr, Paducah, KY 42001 Phone: 270-444-8465

Janet L Owens, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2620 Perkins Creek Dr, Paducah, KY 42001 Phone: 270-444-8465

Jamie Lynn Trout, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2620 Perkins Creek Dr, Paducah, KY 42001 Phone: 270-444-8465

News Archive

Tumor microenvironment acts as source of resistance to cancer therapies

Researchers at Bellvitge Biomedical Research Institute have published a new Oncotarget work which highlights the importance of the tumor environment as a source of resistance to treatment in colorectal cancer, the fourth most common cancer and the leading cause of cancer death worldwide.

UCF to develop safe, inexpensive and effective polio vaccine

An innovative way of making vaccines at the University of Central Florida has attracted the support of the Bill & Melinda Gates Foundation for its potential to make vaccines lessexpensive, more effective and needle free.

Ixazomib's phase 3 study in relapsed/refractory multiple myeloma presented

Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.

Keryx, Aeterna Zentaris execute perifosine license termination and technology transfer agreement

Keryx Biopharmaceuticals, Inc. today announced that the Company and Aeterna Zentaris Inc. have executed a License Termination and Technology Transfer Agreement, whereby the KRX-0401 (perifosine) license agreement has been terminated and all license rights have reverted back to Aeterna Zentaris.

Nanoscale mechanism to externally control the function and action of a protein

"We can switch a protein on and off, and while we have controlled a specific protein, we believe our approach will work with virtually any protein," said Giovanni Zocchi, assistant professor of physics at UCLA, member of the California NanoSystems Institute and leader of the research effort. "This research has the potential to start a new approach to protein engineering."

Read more Medical News

› Verified 4 days ago